Clinical importance of the Mandalay spitting cobra (Naja mandalayensis) in Upper Myanmar – Bites, envenoming and ophthalmia
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Authors
Sai-Sein-Lin-OoMyat-Thet-Nwe
Khin-Maung-Gyi
Than-Aye
Mi-Mi-Khine
Myat-Myat-Thein
Myo-Thant
Pyae-Phyo-Aung
Oakkar-Kyaw-Khant
Aye-Zarchi-San
Du-Wun-Moe
Htay-Aung
O'Shea, Mark
Mahmood, Mohammed Afzal
Peh, Chen Au
White, Julian
Warrell, David A.
Issue Date
2020-06-03
Metadata
Show full item recordAbstract
© 2020 Elsevier Ltd Examination of 18 cobras brought to three hospitals in the Mandalay Region by patients bitten or spat at by them distinguished 3 monocled cobras (Naja kaouthia) and 15 Mandalay spitting cobras (N. mandalayensis), based on their morphological characteristics. We confirm and extend the known distributions and habitats of both N. mandalayensis and N. kaouthia in Upper Myanmar. Clinical symptoms of local and systemic envenoming by N. mandalayensis are described for the first time. These included local swelling, blistering and necrosis and life-threatening systemic neurotoxicity. More information is needed about the clinical phenotype and management of bites by N. mandalayensis, the commoner of the two cobras in Upper Myanmar. Since the current cobra antivenom manufactured in Myanmar has lower pre-clinical efficacy against N. mandalayensis than N. kaouthia, there is a need for more specific antivenom therapy.Citation
Sai-Sein-Lin-Oo et al. (2020) Clinical importance of the Mandalay spitting cobra (Naja mandalayensis) in Upper Myanmar–Bites, envenoming and ophthalmia, Toxicon, 184, pp. 39-47.Publisher
ElsevierJournal
ToxiconPubMed ID
32504626 (pubmed)Additional Links
https://www.sciencedirect.com/science/article/abs/pii/S0041010120302543?via%3Dihub#!Type
Journal articleLanguage
enDescription
This is an accepted manuscript of an article published by Elsevier in Toxicon on 03/06/2020, available online: https://doi.org/10.1016/j.toxicon.2020.05.023 The accepted version of the publication may differ from the final published version.ISSN
0041-0101EISSN
1879-3150ae974a485f413a2113503eed53cd6c53
10.1016/j.toxicon.2020.05.023
Scopus Count
Collections
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by-nc-nd/4.0/
Related articles
- Clinical importance of the Mandalay spitting cobra (Naja mandalayensis) in Upper Myanmar - Bites, envenoming and ophthalmia.
- Authors: Sai-Sein-Lin-Oo, Myat-Thet-Nwe, Khin-Maung-Gyi, Than-Aye, Mi-Mi-Khine, Myat-Myat-Thein, Myo-Thant, Pyae-Phyo-Aung, Oakkar-Kyaw-Khant, Aye-Zarchi-San, Du-Wun-Moe, Htay-Aung, O'Shea M, Mahmood MA, Peh CA, White J, Warrell DA
- Issue date: 2020 Sep
- Species-specific and geographical variation in venom composition of two major cobras in Indian subcontinent: Impact on polyvalent antivenom therapy.
- Authors: Mukherjee AK
- Issue date: 2020 Dec
- Cytotoxicity of Venoms and Cytotoxins from Asiatic Cobras (Naja kaouthia, Naja sumatrana, Naja atra) and Neutralization by Antivenoms from Thailand, Vietnam, and Taiwan.
- Authors: Chong HP, Tan KY, Liu BS, Sung WC, Tan CH
- Issue date: 2022 May 10
- An immunodetection assay developed using cobra cytotoxin-specific antibodies: Potential diagnostics for cobra envenoming.
- Authors: Ong HL, Tan CH, Lee LP, Khor SM, Tan KY
- Issue date: 2022 Sep